Follow The Filings

UNCY Unicycive Therapeutics

Unicycive Therapeutics earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 5.02,8.01,9.01
8-K 8.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q QUARTERLY REPORT
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 8.01
8-K 5.07
DEFA14A CURRENT REPORT
8-K 1.01,9.01
SCHEDULE 13G/A —
10-Q QUARTERLY REPORT
8-K 2.02,9.01
DEF 14A DEFINITIVE PROXY STATEMENT
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 5.02
10-K ANNUAL REPORT
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G/A —

Insider forms

Forms 3, 4 and 5 from EDGAR, 2 rows shown

Filed Form Detail Links
4/A Period May 14, 2026 (2 forms)
4/A Period May 14, 2026 (3 forms)

9 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.